Skip to main content
OpenTrials
Completed

NCT Number: NCT07740850

Virtual Reality for Procedural Pain During IV Cannulation in Children

This study evaluates whether virtual reality (VR)-based distraction can reduce pain during intravenous cannulation and venous blood sampling in children treated in a pediatric emergency department. Children aged 6-11 years who required these procedures received either standard care or VR distraction using age-appropriate audiovisual content. The primary outcome was procedure-related pain measured by the Wong-Baker FACES Pain Rating Scale. Secondary outcomes included procedural duration, cooperation, first-attempt success, behavioral distress, and parental satisfaction. The study also explored whether the effectiveness of VR was associated with patient engagement during the procedure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ege University

Izmir, 35100, Turkey (Türkiye)

About this study

Painful procedures such as intravenous cannulation and venous blood sampling are common in pediatric emergency departments and may lead to distress, anxiety, and negative healthcare experiences. Virtual reality (VR) has emerged as a non-pharmacological intervention that may reduce procedural pain through immersive distraction.

This prospective quasi-experimental study was conducted in a tertiary pediatric emergency department between September 2024 and September 2025. A total of 150 children aged 6-11 years requiring intravenous cannulation or venous blood sampling were included. Participants were enrolled sequentially, with 100 children assigned to the VR group and 50 to standard care. The VR intervention consisted of age-appropriate audiovisual content delivered through a VR headset during the procedure.

The primary outcome was procedure-related pain measured using the Wong-Baker FACES Pain Rating Scale. Secondary outcomes included procedural duration, cooperation, first-attempt success, behavioral distress, parental satisfaction, and VR response. The study aimed to assess whether VR distraction may improve procedural experience and reduce procedure-related pain in pediatric emergency settings.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 6-11 years
  • Requirement for intravenous cannulation or venous blood sampling in the -pediatric emergency department
  • Ability to understand and engage with virtual reality content
  • Written informed consent obtained from parent or legal guardian

Exclusion criteria

  • Visual or hearing impairment preventing VR use
  • Neurological or developmental disorders affecting communication or cooperation
  • Altered level of consciousness
  • Hemodynamic instability requiring immediate intervention
  • Previous participation in the study
  • Refusal of participation by the child or parent/legal guardian
  • Contraindications to virtual reality exposure (e.g., severe motion sickness or intolerance)

Treatment and study plan

Virtual Reality-Based Distraction

Device

Participants received age-appropriate audiovisual distraction through a virtual reality headset (Meta Quest 3S) during intravenous cannulation or venous blood sampling. The intervention aimed to reduce procedural pain and distress by redirecting attention away from the procedure toward immersive VR content.

Primary outcomes

  1. Procedure-related pain

    Time frame: Immediately after the procedure

    Procedure-related pain assessed using the Wong-Baker FACES Pain Rating Scale (WBFPS) following intravenous cannulation or venous blood sampling.

Sponsors and collaborators

Lead sponsor

Ege University

Other

Registry information

Official study title

The Impact of Virtual Reality Distraction on Procedural Pain, Duration, and Parental Satisfaction During Intravenous Cannulation and Blood Sampling in the Pediatric Emergency Department: A Prospective Quasi-Experimental Study

Acronym: VR-PED

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Aug 3, 2026
Registry last updated
Aug 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.